HC Wainwright & Co. Maintains Buy on Compass Pathways, Lowers Price Target to $65

Benzinga Newsdesk www.benzinga.com Neutral 53.1%

Neg 0% Neu 53.1% Pos 0%

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Compass Pathways (NASDAQ:CMPS) with a Buy and lowers the price target from $70 to $65.